Abstract
Variability in presentation and prognosis of transient myeloproliferative disorder (TMD) in infants with Down syndrome (DS) has perplexed clinicians and scientists for decades and is explored in this issue of Blood by Gamis and colleagues from the Children's Oncology Group (COG).
Cite
CITATION STYLE
APA
Roberts, I., & Vyas, P. (2011, December 22). Enigmatic variation. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2011-09-376145
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free